Jonathan Finn - 15 Nov 2023 Form 4/A - Amendment Insider Report for ATOSSA THERAPEUTICS, INC. (ATOS)

Role
Director
Signature
/s/ Heather Rees, as attorney-in-fact for Jonathan Finn
Issuer symbol
ATOS
Transactions as of
15 Nov 2023
Transactions value $
$0
Form type
4/A - Amendment
Filing time
15 Nov 2023, 17:03:55 UTC
Date Of Original Report
15 Nov 2023
Previous filing
15 Nov 2023
Next filing
11 Apr 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATOS Stock Option (right to buy) Award $0 +62.5K $0.00 62.5K 15 Nov 2023 Common Stock 62.5K $0.65 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options shall vest in four equal quarterly installments following November 15, 2023.